Related Experiment Video
Updated: Jun 18, 2026
07:04
Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum
Published on: April 12, 2020
Preview. Mutant CEBPA: Priming Stem Cells for Myeloid Leukemogenesis
Tim C P Somervaille1, Michael L Cleary
1Cancer Research UK Leukaemia Biology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, M20 4BX, UK.
Cell Stem Cell
|November 10, 2009
Summary
Researchers developed a mouse model for acute myeloid leukemia, mimicking common CEBPA gene mutations. This model aids in studying the disease and developing new treatments.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Acute myeloid leukemia (AML) is a heterogeneous cancer.
- CEBPA mutations are common in AML, particularly biallelic mutations.
- Understanding the functional impact of these mutations is crucial.
Purpose of the Study:
- To create a preclinical model for studying CEBPA-mutated AML.
- To investigate the biological consequences of the most frequent biallelic CEBPA mutations.
Main Methods:
- Development of a knockin mouse model.
- Genetic engineering to replicate specific CEBPA mutations.
- Characterization of the mouse model's phenotype.
Main Results:
- Successful generation of a mouse model accurately reflecting human CEBPA mutations in AML.
- The model exhibits characteristics relevant to human disease.
- Provides a platform for further research.
Conclusions:
- The developed mouse model is a valuable tool for AML research.
- Facilitates the study of CEBPA-driven leukemogenesis.
- Supports the development of targeted therapies for AML.
